Faricimab – The Fight Against Retinal Diseases #68

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed non risus. Suspendisse lectus tortor, dignissim sit amet, adipiscing nec, ultricies sed, dolor. Cras elementum ultrices diam. Maecenas ligula massa, varius a, semper congue, euismod non, mi. Proin porttitor, orci nec nonummy molestie, enim est eleifend mi, non fermentum diam nisl sit amet erat. Duis semper. […]

Read More… from Faricimab – The Fight Against Retinal Diseases #68

How Bausch + Lomb is Safely Returning enVista® IOLs to the Market Weeks after TASS Recall #75

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed non risus. Suspendisse lectus tortor, dignissim sit amet, adipiscing nec, ultricies sed, dolor. Cras elementum ultrices diam. Maecenas ligula massa, varius a, semper congue, euismod non, mi. Proin porttitor, orci nec nonummy molestie, enim est eleifend mi, non fermentum diam nisl sit amet erat. Duis semper. […]

Read More… from How Bausch + Lomb is Safely Returning enVista® IOLs to the Market Weeks after TASS Recall #75

Glimmers of Hope: Next-Gen Pediatric Retina Care Promises to Deliver Solutions Once Deemed Out of Reach #64

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed non risus. Suspendisse lectus tortor, dignissim sit amet, adipiscing nec, ultricies sed, dolor. Cras elementum ultrices diam. Maecenas ligula massa, varius a, semper congue, euismod non, mi. Proin porttitor, orci nec nonummy molestie, enim est eleifend mi, non fermentum diam nisl sit amet erat. Duis semper. […]

Read More… from Glimmers of Hope: Next-Gen Pediatric Retina Care Promises to Deliver Solutions Once Deemed Out of Reach #64

Tackling the Myopia Crisis With Contact Lens-Based Drug Delivery #60

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed non risus. Suspendisse lectus tortor, dignissim sit amet, adipiscing nec, ultricies sed, dolor. Cras elementum ultrices diam. Maecenas ligula massa, varius a, semper congue, euismod non, mi. Proin porttitor, orci nec nonummy molestie, enim est eleifend mi, non fermentum diam nisl sit amet erat. Duis semper. […]

Read More… from Tackling the Myopia Crisis With Contact Lens-Based Drug Delivery #60

How Bausch + Lomb is Safely Returning enVista® IOLs to the Market Weeks after TASS Recall #54

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed non risus. Suspendisse lectus tortor, dignissim sit amet, adipiscing nec, ultricies sed, dolor. Cras elementum ultrices diam. Maecenas ligula massa, varius a, semper congue, euismod non, mi. Proin porttitor, orci nec nonummy molestie, enim est eleifend mi, non fermentum diam nisl sit amet erat. Duis semper. […]

Read More… from How Bausch + Lomb is Safely Returning enVista® IOLs to the Market Weeks after TASS Recall #54

Reaching for the Stars with Aflibercept 8 mg Trial Result Release #24

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed non risus. Suspendisse lectus tortor, dignissim sit amet, adipiscing nec, ultricies sed, dolor. Cras elementum ultrices diam. Maecenas ligula massa, varius a, semper congue, euismod non, mi. Proin porttitor, orci nec nonummy molestie, enim est eleifend mi, non fermentum diam nisl sit amet erat. Duis semper. […]

Read More… from Reaching for the Stars with Aflibercept 8 mg Trial Result Release #24

Harrow Expands VEVYE Access for All Program, Offering $59 FDA-Approved Dry Eye Treatment #21

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed non risus. Suspendisse lectus tortor, dignissim sit amet, adipiscing nec, ultricies sed, dolor. Cras elementum ultrices diam. Maecenas ligula massa, varius a, semper congue, euismod non, mi. Proin porttitor, orci nec nonummy molestie, enim est eleifend mi, non fermentum diam nisl sit amet erat. Duis semper. […]

Read More… from Harrow Expands VEVYE Access for All Program, Offering $59 FDA-Approved Dry Eye Treatment #21

Tackling the Myopia Crisis With Contact Lens-Based Drug Delivery #18

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed non risus. Suspendisse lectus tortor, dignissim sit amet, adipiscing nec, ultricies sed, dolor. Cras elementum ultrices diam. Maecenas ligula massa, varius a, semper congue, euismod non, mi. Proin porttitor, orci nec nonummy molestie, enim est eleifend mi, non fermentum diam nisl sit amet erat. Duis semper. […]

Read More… from Tackling the Myopia Crisis With Contact Lens-Based Drug Delivery #18

Local Optometrists Could Solve the NHS Eye Care Crisis According to New Study #15

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed non risus. Suspendisse lectus tortor, dignissim sit amet, adipiscing nec, ultricies sed, dolor. Cras elementum ultrices diam. Maecenas ligula massa, varius a, semper congue, euismod non, mi. Proin porttitor, orci nec nonummy molestie, enim est eleifend mi, non fermentum diam nisl sit amet erat. Duis semper. […]

Read More… from Local Optometrists Could Solve the NHS Eye Care Crisis According to New Study #15

Two Rival Treatments Approved for Geographic Atrophy Under the Spotlight #2

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed non risus. Suspendisse lectus tortor, dignissim sit amet, adipiscing nec, ultricies sed, dolor. Cras elementum ultrices diam. Maecenas ligula massa, varius a, semper congue, euismod non, mi. Proin porttitor, orci nec nonummy molestie, enim est eleifend mi, non fermentum diam nisl sit amet erat. Duis semper. […]

Read More… from Two Rival Treatments Approved for Geographic Atrophy Under the Spotlight #2